Literature DB >> 15231241

The role of iron neurotoxicity in ischemic stroke.

Magdy H Selim1, Rajiv R Ratan.   

Abstract

Stroke is the second leading cause of death worldwide, and its incidence is expected to rise with the projected increase in the number of aging population. Disturbances of brain iron homeostasis have been linked to acute neuronal injury following cerebral ischemia. Free iron catalyzes the conversion of superoxide and hydrogen peroxide into hydroxyl radicals, which promote oxidative stress leading to subsequent cell death/apoptosis. In recent years, considerable evidence has emerged regarding the role of iron neurotoxicity following experimental cerebral ischemia. Few clinical studies have also attempted to investigate the role of iron in stroke patients. The present review will examine the currently available evidence for iron-mediated neurotoxicity and the potential mechanisms underlying deregulation of iron homeostasis in the brain following cerebral ischemia. Understanding the changes in brain iron metabolism and its relationship to neuronal injury in ischemic stroke could provide new therapeutic targets to improve the outcome of stroke patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15231241     DOI: 10.1016/j.arr.2004.04.001

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  40 in total

1.  Attenuation of the in vitro neurotoxicity of 316L SS by graphene oxide surface coating.

Authors:  Nishat Tasnim; Alok Kumar; Binata Joddar
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2017-01-07       Impact factor: 7.328

2.  Solid microparticles based on chitosan or methyl-β-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate.

Authors:  Giovanna Rassu; Elena Soddu; Massimo Cossu; Antonio Brundu; Guido Cerri; Nicola Marchetti; Luca Ferraro; Raymond F Regan; Paolo Giunchedi; Elisabetta Gavini; Alessandro Dalpiaz
Journal:  J Control Release       Date:  2015-01-22       Impact factor: 9.776

Review 3.  Role of iron in ischemia-induced neurodegeneration: mechanisms and insights.

Authors:  Gillipsie Minhas; Shweta Modgil; Akshay Anand
Journal:  Metab Brain Dis       Date:  2014-03-11       Impact factor: 3.584

4.  Mfn2-Mediated Preservation of Mitochondrial Function Contributes to the Protective Effects of BHAPI in Response to Ischemia.

Authors:  Xiao-Li Chen; Guo-Ping Zhang; Sheng-Long Guo; Jia-Qi Ding; Jia-Ji Lin; Qian Yang; Zhu-Yi Li
Journal:  J Mol Neurosci       Date:  2017-09-26       Impact factor: 3.444

Review 5.  Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells.

Authors:  Julie A Gaasch; Paul R Lockman; Werner J Geldenhuys; David D Allen; Cornelis J Van der Schyf
Journal:  Neurochem Res       Date:  2007-04-03       Impact factor: 3.996

6.  Small-molecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake.

Authors:  Herbert A Wetli; Peter D Buckett; Marianne Wessling-Resnick
Journal:  Chem Biol       Date:  2006-09

7.  Soluble neuroprotective antioxidant uric acid analogs ameliorate ischemic brain injury in mice.

Authors:  Frank Haberman; Sung-Chun Tang; Thiruma V Arumugam; Dong-Hoon Hyun; Qian-Sheng Yu; Roy G Cutler; Zhihong Guo; Harold W Holloway; Nigel H Greig; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2007-08-10       Impact factor: 3.843

Review 8.  The presence and role of iron in mild traumatic brain injury: an imaging perspective.

Authors:  Eric J Nisenbaum; Dmitry S Novikov; Yvonne W Lui
Journal:  J Neurotrauma       Date:  2014-01-09       Impact factor: 5.269

9.  Elevated metals compromise repair of oxidative DNA damage via the base excision repair pathway: implications of pathologic iron overload in the brain on integrity of neuronal DNA.

Authors:  Hui Li; Rafal Swiercz; Ella W Englander
Journal:  J Neurochem       Date:  2009-07-08       Impact factor: 5.372

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.